Company Filing History:
Years Active: 2005-2020
Title: The Innovative Contributions of Sarah Helen Main
Introduction
Sarah Helen Main is a prominent inventor based in Royston, GB. She has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of 6 patents to her name, her work has had a substantial impact on therapeutic methods.
Latest Patents
Among her latest patents are groundbreaking innovations related to human antibodies against eotaxin. These patents focus on specific binding members directed to eotaxin-1, particularly human antibodies and antibody fragments that neutralize eotaxin-1 activity. The patents detail the antibodies VH and/or VL domain of the scFv fragment termed CAT-212 and the IgG4 antibody termed CAT-213. They also describe methods of obtaining specific binding members that bind eotaxin, as well as compositions containing these members for therapeutic use in humans and animals.
Career Highlights
Throughout her career, Sarah has worked with notable companies such as Medimmune Limited and Cambridge Antibody Technology Limited. Her experience in these organizations has allowed her to refine her expertise in antibody development and therapeutic applications.
Collaborations
Sarah has collaborated with esteemed colleagues, including Tristan J Vaughan and Alison Jane Wilton. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Sarah Helen Main's contributions to biotechnology, particularly in the development of human antibodies, showcase her innovative spirit and dedication to advancing medical therapies. Her work continues to influence the field and improve treatment options for various conditions.